Practical Considerations for Recognizing, Diagnosing, and Managing Non-Cystic Fibrosis Bronchiectasis: A Care Team Forum®

Program Overview

The goal of this activity is to raise awareness of and educate on the diagnostic testing and multifaceted management essential for patients with NCFBE. Clinicians will learn about the important role of neutrophil serine proteases (NSPs) in NCFBE pathophysiology, including emerging therapies that target neutrophilic inflammation. An experienced patient with NCFBE shares her difficult diagnostic and therapeutic journey and provides impactful insights for clinical care.

Credit Expired

CE Credit Expired

Expires: June 27, 2023

Target Audience

This activity is intended for pulmonary, infectious diseases, radiology, and primary care clinicians who manage patients with non-cystic fibrosis bronchiectasis (NCFBE).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Apply current criteria for diagnosing non-cystic fibrosis bronchiectasis (NCFBE)
Employ current management strategies for the treatment of patients with NCFBE
Examine the role of neutrophil serine proteases (NSPs) in the pathophysiology of NCFBE
Assess the potential impact of emerging therapies targeting NSPs on the treatment of NCFBE

Activity Faculty

Doreen J. Addrizzo-Harris, MD (Chair)

Professor, Medicine
Associate Director, Clinical and Academic Affairs
Director, NYU Bronchiectasis/NTM Program
NYU Grossman School of Medicine
New York, NY

Charles L. Daley, MD

Chief, Division of Mycobacterial & Respiratory Infections
Professor, Medicine
National Jewish Health
Denver, CO

Anne E. O’Donnell, MD

Professor, Medicine
Chief, Division of Pulmonary, Critical Care and Sleep Medicine
The Nehemiah and Naomi Cohen Chair in Pulmonary Disease Research
Georgetown University Medical Center
Washington, DC

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by independent medical education grants from Insmed

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 